NexgenRx Inc.
NEGXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 19% | 11.1% | 4.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 79.6% | 78.1% | 68.2% | 71.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 14.1% | 7.4% | 13.5% | 36.5% |
| Net Income | $0 | -$0 | -$0 | $0 |
| % Margin | 3.7% | -2.4% | -0.2% | 34.1% |
| EPS Diluted | 0.005 | -0.005 | -0 | 0.054 |
| % Growth | 206.4% | -1,649% | -100.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |